The Impact of SARS-CoV-2 nsp14 Proofreading on Nucleoside Antiviral Activity: Insights from Genetic and Pharmacological Investigations
Peng, J.-Y.; Lahser, F.; Warren, C.; He, X.; Murray, E.; Wang, D.
Show abstract
Nucleoside analogues are a class of well-established antiviral agents that act by being directly incorporated into the viral genome during the replication process, resulting in chain termination or the induction of lethal mutations. While many nucleoside analogues have exhibited broad-spectrum activity against a wide range of viruses, their effectiveness against SARS-CoV-2 is limited. The lack of activity is hypothesized to be attributed to the proofreading function of viral nsp14 exonuclease. In this study, the role of the nsp14 proofreading in modulating nucleoside antiviral activity was investigated using genetic and pharmacological approaches. Introduction of exonuclease attenuation or disabling mutations to nsp14 led to either severe replication defect or increased sensitivity of SARS-CoV-2 and SARS-CoV replicons to specific nucleoside analogues. In contrast, repurposing of HCV NS5A inhibitors to suppress nsp14 exonuclease activity is insufficient to enhance the potency of nucleoside analogues. These findings provided further support for nsp14 as a target for SARS-CoV-2 antiviral development and highlighted the complex interplay between nsp14 proofreading and RNA replication.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Screening and Identification of Lassa Virus Endonuclease-targeting Inhibitors from a Fragment-based Drug Development Library 96%
- A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors 96%
- SARS-CoV-2 Permissive Glioblastoma Cell Line for High Throughput Antiviral Screening 95%
Similar papers in this journal
- Allosteric inhibitors of Zika virus NS2B-NS3 protease targeting protease in super-open conformation 96%
- Kite-shaped molecules block SARS-CoV-2 cell entry at a post-attachment step 96%
- Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening. 95%
Similar papers in this journal
- Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase 95%
- Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants 95%
- In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance. 95%
Similar papers in this journal
- Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants 95%
- High throughput Bioluminescent assay to characterize and monitor the activity of SARS-CoV-2 Methyltransferases 94%
- Metal Coordinating Inhibitors of Rift Valley Fever virus Replication 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.